MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 373 filers reported holding MEDIVATION INC in Q2 2015. The put-call ratio across all filers is 0.33 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $60,357,000 | +6.3% | 1,000,951 | -18.9% | 0.13% | +18.7% |
| Q1 2016 | $56,763,000 | -13.1% | 1,234,512 | -8.7% | 0.11% | +0.9% |
| Q4 2015 | $65,334,000 | -8.6% | 1,351,549 | -19.6% | 0.11% | -9.4% |
| Q3 2015 | $71,464,000 | -39.3% | 1,681,504 | +63.1% | 0.12% | -30.4% |
| Q2 2015 | $117,718,000 | -13.4% | 1,030,811 | -2.1% | 0.17% | -11.1% |
| Q1 2015 | $135,955,000 | +17.9% | 1,053,349 | -9.0% | 0.19% | +18.1% |
| Q4 2014 | $115,310,000 | -14.3% | 1,157,616 | -14.9% | 0.16% | -14.0% |
| Q3 2014 | $134,557,000 | +37.2% | 1,360,949 | +7.0% | 0.19% | +29.2% |
| Q2 2014 | $98,080,000 | +20.2% | 1,272,436 | +0.4% | 0.14% | +16.1% |
| Q1 2014 | $81,573,000 | +6.7% | 1,267,248 | +5.8% | 0.12% | +0.8% |
| Q4 2013 | $76,444,000 | +23.4% | 1,197,813 | +15.9% | 0.12% | +4.2% |
| Q3 2013 | $61,946,000 | – | 1,033,466 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 4,397,838 | $212,591,000 | 78.82% |
| HealthCor Management, L.P. | 2,300,000 | $111,182,000 | 6.75% |
| Redmile Group, LLC | 1,599,393 | $77,315,000 | 5.79% |
| Marcus Capital, LLC | 104,900 | $5,071,000 | 5.39% |
| BB BIOTECH AG | 2,581,112 | $124,771,000 | 3.52% |
| Hatteras Investment Partners, LP | 47,150 | $2,279,000 | 2.98% |
| Opus Point Partners Management, LLC | 91,310 | $4,414,000 | 2.92% |
| TORRAY INVESTMENT PARTNERS LLC | 793,000 | $38,334,000 | 2.85% |
| Selkirk Management LLC | 92,000 | $4,447,000 | 2.62% |
| MONTAGE INVESTMENTS, LLC | 25,520 | $1,234,000 | 2.43% |